Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2023
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study
Alberto J Espay, Robert A Hauser, Rohit Dhall, et al.
Parkinsonism & Related Disorders
|
January 14, 2020
Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study
Donald G Grosset, Rohit Dhall, Tanya Gurevich, et al.
The International Journal of Neuroscience
|
July 25, 2013
Distinguishing the tremor of Parkinson's disease from essential tremor: finger displacement
Abraham Lieberman, Rohit Dhall, Sara Dhanani, et al.
Research Square
|
December 11, 2025
A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson's Disease
A Journey Eubank, Abhilash Thatikala, Maryam Y Garza, et al.
Journal of Neurosurgery
|
March 17, 2018
Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease
Tsinsue Chen, Zaman Mirzadeh, Kristina M Chapple, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
February 1, 2019
An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor
Rajesh Pahwa, Rohit Dhall, Jill Ostrem, et al.
Frontiers in Neurology
|
December 6, 2021
Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol
Kristina J Pfeifer, Alex J Cook, Jessica K Yankulova, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2023
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
C Warren Olanow, Robert A Hauser, Daniel J Burdick, et al.
Plos One
|
December 9, 2014
No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial
Chizoba C Umeh, Adriana Pérez, Erika F Augustine, et al.
Neurology. Clinical Practice
|
March 1, 2017
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy
Alberto J Espay, Fernando L Pagan, Benjamin L Walter, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2023
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study
Alberto J Espay, Robert A Hauser, Rohit Dhall, et al.
Parkinsonism & Related Disorders
|
January 14, 2020
Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study
Donald G Grosset, Rohit Dhall, Tanya Gurevich, et al.
The International Journal of Neuroscience
|
July 25, 2013
Distinguishing the tremor of Parkinson's disease from essential tremor: finger displacement
Abraham Lieberman, Rohit Dhall, Sara Dhanani, et al.
Research Square
|
December 11, 2025
A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson's Disease
A Journey Eubank, Abhilash Thatikala, Maryam Y Garza, et al.
Journal of Neurosurgery
|
March 17, 2018
Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease
Tsinsue Chen, Zaman Mirzadeh, Kristina M Chapple, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
February 1, 2019
An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor
Rajesh Pahwa, Rohit Dhall, Jill Ostrem, et al.
Frontiers in Neurology
|
December 6, 2021
Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol
Kristina J Pfeifer, Alex J Cook, Jessica K Yankulova, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2023
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
C Warren Olanow, Robert A Hauser, Daniel J Burdick, et al.
Plos One
|
December 9, 2014
No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial
Chizoba C Umeh, Adriana Pérez, Erika F Augustine, et al.
Neurology. Clinical Practice
|
March 1, 2017
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy
Alberto J Espay, Fernando L Pagan, Benjamin L Walter, et al.
Page
of 5